New York, NY -- (SBWIRE) -- 01/10/2014 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding StemCells Inc. (NASDAQ:STEM) and Immunomedics Inc. (NASDAQ:IMMU).
StemCells Inc. (NASDAQ:STEM) a biopharmaceutical company that engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States is currently up (+6.94%) on 1,540,890 shares traded after StemCells, Inc. Expanded Phase I/II Spinal Cord Injury Trial to North America. StemCells Inc. (NASDAQ:STEM) is currently up (+34.05%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about StemCells Inc. (NASDAQ:STEM)
Immunomedics Inc. (NASDAQ:IMMU) a biopharmaceutical company that focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases is currently up (+15.06%) on 4,355,584 shares traded after Immunomedics Announced Initiation of Phase III Clinical Trial of Clivatuzumab Tetraxetan in Patients With Pancreatic Cancer. Immunomedics Inc. (NASDAQ:IMMU) is currently up (+185.78%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Immunomedics Inc. (NASDAQ:IMMU)
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)